Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Neuroprotection Industry
Figure Neuroprotection Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neuroprotection
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neuroprotection
1.2.2 Downstream
Table Application Segment of Neuroprotection
Table Global Neuroprotection Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neuroprotection Market by Type
3.1 By Type
3.1.1 Free Radical Trapping Agents (Antioxidants)
Table Major Company List of Free Radical Trapping Agents (Antioxidants)
3.1.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
Table Major Company List of Glutamate Antagonists (Anti-Excitotoxic Agents)
3.1.3 Apoptosis Inhibitors
Table Major Company List of Apoptosis Inhibitors
3.1.4 Anti-inflammatory Agents
Table Major Company List of Anti-inflammatory Agents
3.1.5 Neurotrophic Factors (NTFs)
Table Major Company List of Neurotrophic Factors (NTFs)
3.1.6 Metal Ion Chelators
Table Major Company List of Metal Ion Chelators
3.1.7 Stimulants
Table Major Company List of Stimulants
3.1.8 Others
Table Major Company List of Others
3.2 Market Size
Table Global Neuroprotection Market 2016-2020, by Type, in USD Million
Figure Global Neuroprotection Market Growth 2016-2020, by Type, in USD Million
Table Global Neuroprotection Market 2016-2020, by Type, in Volume
Figure Global Neuroprotection Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Neuroprotection Market Forecast 2021-2026, by Type, in USD Million
Table Global Neuroprotection Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Daiichi Sankyo Company (Company Profile, Sales Data etc.)
4.1.1 Daiichi Sankyo Company Profile
Table Daiichi Sankyo Company Overview List
4.1.2 Daiichi Sankyo Company Products & Services
4.1.3 Daiichi Sankyo Company Business Operation Conditions
Table Business Operation of Daiichi Sankyo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.2.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.2.2 Eli Lilly and Company Products & Services
4.2.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Allergan (Company Profile, Sales Data etc.)
4.3.1 Allergan Profile
Table Allergan Overview List
4.3.2 Allergan Products & Services
4.3.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
4.4.1 Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Overview List
4.4.2 Dr. Reddy’s Laboratories Products & Services
4.4.3 Dr. Reddy’s Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.5.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.5.2 Teva Pharmaceutical Products & Services
4.5.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis (Company Profile, Sales Data etc.)
4.6.1 Novartis Profile
Table Novartis Overview List
4.6.2 Novartis Products & Services
4.6.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 AstraZeneca (Company Profile, Sales Data etc.)
4.7.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.7.2 AstraZeneca Products & Services
4.7.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Astrocyte Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Astrocyte Pharmaceuticals Profile
Table Astrocyte Pharmaceuticals Overview List
4.8.2 Astrocyte Pharmaceuticals Products & Services
4.8.3 Astrocyte Pharmaceuticals Business Operation Conditions
Table Business Operation of Astrocyte Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.9.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.9.2 F. Hoffmann-La Roche Products & Services
4.9.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Biogen (Company Profile, Sales Data etc.)
4.10.1 Biogen Profile
Table Biogen Overview List
4.10.2 Biogen Products & Services
4.10.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neuroprotection Sales Revenue 2016-2020, by Company, in USD Million
Table Global Neuroprotection Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Neuroprotection Sales Revenue Share in 2020, by Company, in USD Million
Table Global Neuroprotection Sales Volume 2016-2020, by Company, in Volume
Table Global Neuroprotection Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Neuroprotection Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neuroprotection Market Concentration, in 2020
Figure Europe Neuroprotection Market Market Concentration, in 2020
Figure Asia-Pacific Neuroprotection MMarket Concentration, in 2020
Figure South America Neuroprotection Market Concentration, in 2020
Figure Middle East & Africa Neuroprotection Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Prevention
Figure Neuroprotection Demand in Prevention, 2016-2020, in USD Million
Figure Neuroprotection Demand in Prevention, 2016-2020, in Volume
6.1.2 Demand in Treatment
Figure Neuroprotection Demand in Treatment, 2016-2020, in USD Million
Figure Neuroprotection Demand in Treatment, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neuroprotection Demand Forecast 2021-2026, by Application, in USD Million
Figure Neuroprotection Market Growth 2021-2026, by Application, in USD Million
Figure Neuroprotection Market Share in 2026, by Application, in USD Million
Table Neuroprotection Demand Forecast 2021-2026, by Application, in Volume
Table Neuroprotection Market Growth 2021-2026, by Application, in Volume
Table Neuroprotection Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Neuroprotection Production 2016-2020, by Region, in USD Million
Table Neuroprotection Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Neuroprotection Market 2016-2020, by Region, in USD Million
Table Global Neuroprotection Market Share 2016-2020, by Region, in USD Million
Table Global Neuroprotection Market 2016-2020, by Region, in Volume
Table Global Neuroprotection Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neuroprotection Market Size and Growth 2016-2020, in USD Million
Figure North America Neuroprotection Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neuroprotection Market Size 2016-2020, by Country, in USD Million
Table North America Neuroprotection Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neuroprotection Market Size and Growth 2016-2020, in USD Million
Figure Europe Neuroprotection Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neuroprotection Market Size 2016-2020, by Country, in USD Million
Table Europe Neuroprotection Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neuroprotection Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Neuroprotection Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neuroprotection Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Neuroprotection Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neuroprotection Market Size and Growth 2016-2020, in USD Million
Figure South America Neuroprotection Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neuroprotection Market Size 2016-2020, by Country, in USD Million
Table South America Neuroprotection Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neuroprotection Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Neuroprotection Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neuroprotection Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Neuroprotection Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neuroprotection Market Forecast 2021-2026, by Region, in USD Million
Table Neuroprotection Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Neuroprotection
2. Table Application Segment of Neuroprotection
3. Table Global Neuroprotection Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Glutamate Antagonists (Anti-Excitotoxic Agents)
5. Table Major Company List of Apoptosis Inhibitors
6. Table Major Company List of Anti-inflammatory Agents
7. Table Major Company List of Neurotrophic Factors (NTFs)
8. Table Major Company List of Metal Ion Chelators
9. Table Major Company List of Stimulants
10. Table Major Company List of Others
11. Table Global Neuroprotection Market 2016-2020, by Type, in USD Million
12. Table Global Neuroprotection Market 2016-2020, by Type, in Volume
13. Table Global Neuroprotection Market Forecast 2021-2026, by Type, in USD Million
14. Table Global Neuroprotection Market Forecast 2021-2026, by Type, in Volume
15. Table Daiichi Sankyo Company Overview List
16. Table Business Operation of Daiichi Sankyo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Eli Lilly and Company Overview List
18. Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Allergan Overview List
20. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Dr. Reddy’s Laboratories Overview List
22. Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Teva Pharmaceutical Overview List
24. Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Novartis Overview List
26. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table AstraZeneca Overview List
28. Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Astrocyte Pharmaceuticals Overview List
30. Table Business Operation of Astrocyte Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table F. Hoffmann-La Roche Overview List
32. Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Biogen Overview List
34. Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Global Neuroprotection Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Neuroprotection Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Neuroprotection Sales Volume 2016-2020, by Company, in Volume
38. Table Global Neuroprotection Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Neuroprotection Demand Forecast 2021-2026, by Application, in USD Million
42. Table Neuroprotection Demand Forecast 2021-2026, by Application, in Volume
43. Table Neuroprotection Market Growth 2021-2026, by Application, in Volume
44. Table Neuroprotection Market Share in 2026, by Application, in Volume
45. Table Neuroprotection Production 2016-2020, by Region, in USD Million
46. Table Neuroprotection Production 2016-2020, by Region, in Volume
47. Table Global Neuroprotection Market 2016-2020, by Region, in USD Million
48. Table Global Neuroprotection Market Share 2016-2020, by Region, in USD Million
49. Table Global Neuroprotection Market 2016-2020, by Region, in Volume
50. Table Global Neuroprotection Market Share 2016-2020, by Region, in Volume
51. Table North America Neuroprotection Market Size 2016-2020, by Country, in USD Million
52. Table North America Neuroprotection Market Size 2016-2020, by Country, in Volume
53. Table Europe Neuroprotection Market Size 2016-2020, by Country, in USD Million
54. Table Europe Neuroprotection Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Neuroprotection Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Neuroprotection Market Size 2016-2020, by Country, in Volume
57. Table South America Neuroprotection Market Size 2016-2020, by Country, in USD Million
58. Table South America Neuroprotection Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Neuroprotection Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Neuroprotection Market Size 2016-2020, by Country, in Volume
61. Table Neuroprotection Market Forecast 2021-2026, by Region, in USD Million
62. Table Neuroprotection Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List